RAIN THERAPEUTICS INC's ticker is RAIN and the CUSIP is 75082Q105. A total of 41 filers reported holding RAIN THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $26,033 | +9.2% | 2,978,660 | 0.0% | 1.71% | +7.5% |
| Q4 2022 | $23,829 | -99.8% | 2,978,660 | +28.0% | 1.60% | +100.9% |
| Q3 2022 | $11,354,000 | -12.2% | 2,326,660 | 0.0% | 0.79% | -18.8% |
| Q2 2022 | $12,936,000 | +9.7% | 2,326,660 | 0.0% | 0.98% | +7.9% |
| Q1 2022 | $11,796,000 | -60.6% | 2,326,660 | 0.0% | 0.91% | -49.2% |
| Q4 2021 | $29,967,000 | -13.9% | 2,326,660 | 0.0% | 1.78% | +26.0% |
| Q3 2021 | $34,807,000 | -12.4% | 2,326,660 | -11.4% | 1.41% | +4.7% |
| Q2 2021 | $39,734,000 | – | 2,626,660 | – | 1.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,571,379 | $7,967,000 | 2.01% |
| Cormorant Asset Management, LP | 2,326,660 | $11,796,000 | 0.91% |
| BVF INC/IL | 3,526,729 | $17,881,000 | 0.72% |
| Boxer Capital, LLC | 1,175,000 | $5,957,000 | 0.31% |
| Perceptive Advisors | 2,483,619 | $12,592,000 | 0.25% |
| Logos Global Management LP | 134,194 | $680,000 | 0.09% |
| Lumina Fund Management LLC | 6,000 | $30,000 | 0.01% |
| Woodline Partners LP | 119,700 | $607,000 | 0.01% |
| Trexquant Investment LP | 28,373 | $144,000 | 0.01% |
| Alyeska Investment Group, L.P. | 125,000 | $634,000 | 0.01% |